Notice of Intent to Publish a Request for Applications for AIDS Mental Health Research Programs (AMHRP) at RCMI-Eligible Institutions (R21/R33)

Notice Number: NOT-MH-10-011

Key Dates
Release Date: March 5, 2010

Issued by
National Institute of Mental Health (NIMH), (http://www.nimh.nih.gov)

Purpose

The National Institute of Mental Health (NIMH), Division of AIDS Research (DAR), intends to promote a new initiative by publishing a Request for Applications (RFA) that solicits research grant applications from Research Centers for Minority Institutions (RCMIs) to develop AIDS Mental Health Research Programs (AMHRP). 

This Notice is being provided to encourage investigators with expertise in the areas of mental health HIV research to consider applying for this new RFA and to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

The RFA, which will utilize the NIH Exploratory/Developmental Phased Innovation (R21/R33), is expected to be published in the Spring or Summer of 2010 with an expected receipt date in September 2010.

Research Initiative Details

This program will support mental health HIV/AIDS research projects that are innovative and novel and that exhibit the potential to advance the field.  This RFA will aim to assist RCMI-supported scientists forge new and more advanced HIV studies in the behavioral, clinical and neuroscience disciplines.  The work supported under this funding opportunity is expected to galvanize the development of fundable behavioral and CNS-related research by and for underrepresented racial and ethnic scientists involved in HIV research. It is the intent of the RFA to facilitate high quality, state-of-the-art, federally-funded mental health-related research in DAR priority areas involving prevention, therapeutics, neuropsychiatry, pathophysiology, and other AIDS-related priority areas in domestic and international settings http://www.nimh.nih.gov/about/organization/dahbr/center-for-mental-health-research-on-aids/index.shtml.

This R21/R33 RFA will provide support for a first phase (R21) for initial, milestone-driven, “proof of concept” studies, and a second phase (R33) for the expanded development of successful ideas or approaches from the R21 phase. Appropriate activities and suggested research questions will be detailed in the RFA.

Both phases should:

  • Involve a partnership between the RCMI and other experienced research intensive institution(s) or research teams (partnership with multiple RCMIs is acceptable if resources and expertise can be demonstrated for a given area at RCMIs in question);
  • Conduct two of the three (or more) pilot studies by a person in training under supervision of competent, experienced mentor and should build capacity, as necessary, in the proposed research area to enable further research to take place
  • Lead to pursuit of translational HIV research in biological or behavioral or social or clinical sciences;
  • Represent a thematic HIV research focus in prevention, therapeutics, neuropsychiatry, pathophysiology or other CMHRA priority areas in either domestic and international settings

 APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME. 

Inquiries

Interested parties are encouraged to contact:

David M. Stoff, Ph.D.
Division of AIDS Research
National Institute of Mental Health
6001 Executive Boulevard, Room 6210, MSC 9619
Bethesda, MD 20892-9619
Telephone: (301) 443-4625
FAX:  (301) 443-9719
Email: [email protected]